C2i Genomics vs Veracyte, Inc.
C2i Genomics
C2i Genomics is now part of Veracyte. We encourage you to follow Veracyte on LinkedIn
26 employees · est. 2019 · New York, United States
Veracyte, Inc.
Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc
748 employees · est. 2008 · South San Francisco, United...
Veracyte, Inc. is the older company (2019 vs 2008); Veracyte, Inc. is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | C2i Genomics | Veracyte, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2008 older |
| Headquarters | ||
| Headquarters | New York, United States | South San Francisco, United States |
| Employees | ||
| Employees | 26 | 748 larger |
| Industry | ||
| Industry | Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $112.00M | $1.15B |
| Funding Rounds | ||
| Funding Rounds | 2 | 12 |
| Services | ||
| Services | Not tracked yet | Genomic Sequencing Classifier, Bladder Genomic Classifier, Prostate Genomic Classifier, Breast Risk of Recurrence Test, Monitoring Test for MIBC |
| Target Customers | ||
| Target Customers | Not tracked yet | Clinicians, Cancer Patients, Healthcare Providers, Research Scientists, Oncology Clinics |
| Taxonomy | ||
| Taxonomy | C2i GenomicsVeracyteGenomicsMedical DiagnosticsCancer DiagnosisAcquisition +3 | Genomic DiagnosticsCancer DiagnosticsMolecular DiagnosticsThyroid Cancer TestingLung Cancer TestingBreast Cancer Testing +9 |
| Website | ||
| Website | c2i-genomics.com | veracyte.com |
About C2i Genomics
C2i Genomics is a company in the Health Care industry, founded in 2019 and headquartered in the United States. The company recently received a $100.00M Series B investment on April 15, 2021, with participation from notable investors including LionBird, Casdin Capital, iGlobe Partners, Driehaus Capit...
About Veracyte, Inc.
Veracyte, Inc., founded in 2008 and headquartered in the United States, operates within the Biotechnology and Health Care industries. The company's slogan, "Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.," encapsulates its core mission: delivering high-value diagnostic insights that...
Also comparing in this category
Comparing more than these two?
Get C2i Genomics, Veracyte, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does C2i Genomics compare?
A PDF of C2i Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare C2i Genomics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at C2i Genomics on 12 Sep 2024, and Veracyte, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
